"The growth in the group’s core hospital and healthcare segment was attributed to sustained demand for healthcare services, higher revenue intensity, and inflation-adjusted price adjustments," state analysts Amanda Tan and Andy Sim in their Dec 2 note.
DBS Group Research has raised its target price for IHH Healthcare (SGX:Q0F) following it latest earnings that suggest the multi-market provider of healthcare services is poised for further growth.
For its 9MFY2024 ended Sept, IHH recorded patmi of RM1.7 billion, up 21% y-o-y.

